NasdaqCM:KRROBiotechs
Korro Bio (KRRO) Losses Of US$117.3 Million Test Bullish Narratives On Profitability
Korro Bio (KRRO) has reported its FY 2025 numbers with Q4 revenue of US$1.3 million, a basic EPS loss of US$5.32 and a net income loss of US$50.0 million. Its trailing 12 month figures show revenue of US$6.4 million and a basic EPS loss of US$12.48 tied to a net loss of US$117.3 million. Over recent quarters the company has seen revenue move from US$2.3 million in Q4 FY 2024 to between US$1.1 million and US$2.6 million across FY 2025. This has come alongside quarterly basic EPS losses ranging...